surfac
layer
protein
probiot
lactobacilli
theoret
effici
epitopedisplay
scaffold
oral
vaccin
deliveri
due
high
express
level
surfac
local
studi
construct
genet
modifi
lactobacillu
acidophilu
strain
express
membran
proxim
extern
region
mper
human
immunodefici
viru
type
within
context
major
slayer
protein
slpa
intragastr
immun
mice
recombin
induc
mperspecif
slayer
proteinspecif
antibodi
serum
mucos
secret
moreov
analysi
system
slpaspecif
cytokin
reveal
respons
appear
domin
find
demonstr
potenti
use
lactobacillu
slayer
protein
develop
oral
vaccin
target
specif
peptid
predominantli
transmit
mucos
surfac
vaccin
design
evalu
focus
primarili
system
immun
respons
mucos
immun
system
mani
respect
independ
system
immun
system
human
intestin
vagin
iga
produc
local
induct
mucos
immun
best
achiev
via
mucos
infect
vaccin
passiv
transfer
studi
use
broadli
neutral
antibodi
bnab
shown
protect
mucos
transmiss
review
induct
bnab
proven
extraordinarili
difficult
neutral
epitop
often
structur
complex
difficult
faith
recapitul
longterm
immun
matur
need
acquir
extens
hypermut
describ
neutral
igg
neutral
antibodi
show
autoreact
howev
bnab
may
essenti
protect
mucosa
strong
evid
protect
iga
typic
reli
classic
viru
neutral
iga
sequest
viru
mucu
steric
hinder
bind
mucos
epithelia
target
viru
destruct
via
polymer
immunoglobulin
receptor
pigr
also
grow
interest
protect
potenti
nonneutr
igg
mechan
nonneutr
protect
includ
antibodydepend
cellular
cytotox
antibodydepend
cellmedi
viru
inhibit
innat
immun
function
phagocytosi
mediat
fc
domain
antibodi
whether
mucos
vaccin
induc
protect
antibodi
respons
sort
uncertain
lactobacilli
import
group
gram
posit
lactic
acid
bacteria
use
food
preserv
food
bioprocess
probiot
lactobacilli
increasingli
investig
biolog
vaccin
vector
proof
principl
studi
perform
use
recombin
lactobacilli
oral
vaccin
tetanu
toxin
anthrax
rotaviru
brucella
aboru
sar
coronaviru
human
papilloma
viru
helicobact
pylori
other
review
xin
colleagu
employ
recombin
lactococcu
lacti
induc
hivspecif
immun
respons
report
clearli
demonstr
potenti
lactic
acid
bacteria
vaccin
vector
two
concern
approach
employ
first
cholera
toxin
use
adjuv
accept
use
human
second
iiib
env
loop
use
immunogen
unlik
induc
broadli
protect
immun
respons
thu
altern
adjuv
antigen
design
express
need
success
antihiv
vaccin
use
lactic
acid
bacteria
other
shown
sever
cell
surfac
compon
probiot
bacteria
recogn
immun
cell
via
pattern
recognit
receptor
particular
lipoteicho
acid
peptidoglycan
pg
muramyl
dipeptid
subcompon
pg
known
major
immun
stimul
recogn
heterodimer
tolllik
receptor
tlr
nucleotidebind
oligomer
domain
respect
capac
interact
innat
immun
system
explain
lactobacilli
effect
induc
mucos
iga
review
probiot
strain
lactobacillu
acidophilu
ncfm
particularli
promis
oral
vaccin
vector
acid
bile
toler
express
mucusbind
protein
associ
intestin
mucosa
bind
dendrit
cell
dc
dcspecif
intercellular
adhes
molecul
grab
nonintegrin
dcsign
pattern
recognit
receptor
describ
proof
principl
demonstr
mohamadzadeh
et
al
construct
recombin
l
acidophilu
produc
bacillu
anthraci
protect
antigen
succeed
induc
protect
immun
murin
model
construct
recombin
l
acidophilu
vaccin
candid
three
strategi
subcellular
distribut
antigen
cytoplasm
accumul
secret
cell
surfac
display
studi
insert
linear
epitop
membran
proxim
extern
region
mper
highli
express
bacteri
surfac
layer
protein
slpa
l
acidophilu
prototyp
oral
mucos
vaccin
platform
assess
immunogen
mous
model
servic
polici
human
care
use
laboratori
anim
associ
assess
accredit
laboratori
anim
care
intern
aaalac
protocol
approv
colorado
state
univers
institut
anim
care
use
committe
oper
current
approv
assur
anim
welfar
health
monitor
daili
instanc
medic
intervent
effect
anim
human
euthan
everi
effort
made
minim
suffer
lactobacillu
acidophilu
deriv
strain
grown
static
mr
broth
bd
diagnost
spark
md
alon
supplement
erythromycin
em
chloramphenicol
cm
mr
agar
plate
without
antibiot
incub
anaerob
escherichia
coli
strain
grown
aerob
shake
lb
medium
bd
diagnost
without
em
kanamycin
km
bacteri
strain
use
studi
list
tabl
dna
manipul
recombin
modifi
slpa
gene
includ
infram
mper
peptideencod
sequenc
flank
region
gener
overlap
pcr
approxim
kb
dna
fragment
upstream
downstream
region
amplifi
use
primer
pair
chromosom
dna
l
acidophilu
ncfm
use
templat
dna
pcr
product
appli
second
round
pcr
along
connect
kb
fragment
treat
bamhi
hindiii
follow
ligat
digest
result
plasmid
introduc
l
acidophilu
electropor
gene
replac
doubl
crossingov
perform
previous
describ
mutat
slpa
valid
pcr
dna
fragment
encod
matur
mous
fuse
signal
sequenc
l
acidophilu
mub
gene
locustag
overlap
pcr
dna
fragment
amplifi
use
either
l
acidophilu
chromosom
dna
total
mous
cdna
fusion
dna
insert
ecori
eagi
site
establish
plasmid
introduc
l
acidophilu
strain
display
mper
nucleotid
sequenc
primer
describ
tabl
total
protein
bacteria
prepar
bead
beat
lysi
buffer
urea
mm
triscl
ph
experi
cultur
supernat
collect
concentr
ad
volum
trichloroacet
acid
purifi
slayer
protein
prepar
previous
describ
protein
separ
nupag
bistri
gel
mopssd
run
buffer
life
technolog
grand
island
ny
gel
either
stain
coomassi
brilliant
blue
cbb
appli
electroblot
immobilonp
membran
emd
millipor
billerica
protein
blot
incub
bovin
serum
albumin
bsa
phosphat
buffer
salin
pb
includ
monoclon
igg
secondari
antibodi
horseradish
peroxidas
hrp
conjug
antihuman
igg
cell
signal
technolog
inc
danver
use
signal
detect
use
ecl
plu
ge
healthcar
life
scienc
piscataway
nj
visual
molecular
imag
versadoc
biorad
laboratori
hercul
ca
bacteri
cell
overnight
cultur
treat
antibodi
solut
pb
supplement
bsa
incub
alexa
antihuman
igg
life
technolog
solut
forward
scatter
fsc
side
scatter
ssc
fluoresc
intens
stain
cell
suspend
pb
analyz
lsr
ii
flow
cytomet
facsdiva
softwar
bd
bioscienc
san
jose
ca
femal
balbc
mice
week
old
immun
intragastr
ig
genet
modifi
l
acidophilu
strain
bacteri
cell
freshli
prepar
overnight
cultur
suspend
ig
buffer
contain
nahco
soybean
trypsin
inhibitor
three
daili
dose
bacteri
suspens
cfu
administ
mice
micegroup
week
anoth
experi
mice
mice
group
receiv
mper
strain
mice
group
receiv
addit
set
dose
week
mice
euthan
two
week
last
immun
blood
collect
tail
vein
period
cardiac
punctur
termin
cecal
content
suspend
pb
supplement
bsa
supernat
collect
vagin
lavag
prepar
suspend
vagin
fluid
pb
use
pipet
insolubl
debri
remov
centrifug
sampl
store
spleen
peyer
patch
pp
colon
femal
reproduct
tract
frt
also
collect
mice
hous
care
accord
associ
assess
laboratori
anim
care
standard
institut
anim
care
use
committe
guidelin
colorado
state
univers
protocol
singl
cell
suspens
spleen
pp
cell
prepar
mash
tissu
gentlemac
dissoci
miltenyi
biotec
auburn
ca
filter
cell
strainer
isol
lymphocyt
colon
frt
previous
describ
follow
modif
mucu
epithelium
remov
pb
supplement
mm
dithiothreitol
mm
edta
tissu
cut
small
piec
suspend
digest
medium
appli
gentlemac
dissoci
min
incub
addit
dissoci
appli
cell
suspens
transfer
new
tube
cell
strainer
puriti
viabil
isol
immun
cell
valid
flow
cytometri
trypan
blue
stain
b
cell
analyz
stain
antimous
fitc
pacif
blue
biolegend
san
diego
ca
micropl
coat
overnight
synthet
mper
peptid
gneqelleldkwaslwn
biosynthesi
inc
lewisvil
tx
slpa
modifi
slpa
block
bsa
pb
serial
dilut
sera
ad
hrpconjug
antimous
igg
iga
use
detect
antibodi
color
develop
tmb
termin
sulfur
acid
absorb
nm
measur
determin
endpoint
titer
sera
mice
includ
assay
mean
valu
plu
standard
deviat
sd
appli
cutoff
valu
mous
ig
isotyp
elisa
readysetgo
ebiosci
san
diego
ca
use
determin
class
subclass
antimp
ab
synthet
biotinyl
mper
biosynthesi
inc
use
antigenspecif
recognit
secret
l
acidophilu
releas
stimul
murin
splenocyt
peyer
patch
cell
quantifi
elisa
ebiosci
antigenspecif
igaproduc
cell
mucos
tissu
detect
elispot
previous
describ
procedur
perform
accord
previous
describ
method
minor
modif
determin
cytokin
respons
splenocyt
stimul
plate
mper
slayer
protein
l
acidophilu
ncfm
hour
multipl
cytokin
cultur
supernat
quantifi
custom
milliplex
map
kit
emd
millipor
briefli
antibodyimmobil
bead
incub
dilut
cultur
supernat
bead
subsequ
treat
detect
antibodi
well
peconjug
streptavidin
analyz
use
bioplex
system
biorad
laboratori
student
ttest
steeldwass
test
use
jmp
softwar
sa
institut
inc
cari
nc
appli
unpair
multipl
comparison
signific
differ
defin
p
gene
replac
l
acidophilu
modifi
slpa
slpa
modifi
strain
deriv
l
acidophilu
construct
gene
replac
result
strain
l
acidophilu
includ
mperencod
sequenc
integr
slpa
valid
mutat
chromosom
dna
analyz
pcr
use
primer
either
specif
sequenc
flank
replac
region
specif
insert
mperencod
sequenc
fig
shown
fig
similar
size
dna
fragment
amplifi
wild
type
mutant
strain
outer
primer
appli
meanwhil
mperspecif
primer
amplifi
specif
band
mutant
strain
result
confirm
wild
type
slpa
gene
replac
modifi
slpa
gene
total
protein
purifi
slayer
protein
prepar
separ
sdspage
stain
cbb
shown
fig
slayer
protein
exhibit
slightli
greater
molecular
mass
western
blot
analysi
use
mab
specif
label
slayer
protein
addit
smaller
band
like
degrad
slayer
protein
bacteri
cell
also
analyz
flow
cytometri
exhibit
strong
fluoresc
intens
mfi
show
background
fluoresc
mfi
fig
result
indic
epitop
recogn
mab
expos
cell
surfac
provid
addit
adjuv
effect
transform
plasmid
code
matur
form
murin
secretori
express
cassett
term
fig
demonstr
biolog
activ
recombin
cytokin
supernat
ad
mous
lymphocyt
peyer
patch
spleen
level
measur
expect
induc
supernat
strain
fig
anoth
deriv
strain
construct
refer
strain
tabl
genet
modifi
strain
l
acidophilu
administ
mice
via
intragastr
rout
immun
freshli
isol
lymphocyt
analyz
determin
rel
popul
cell
among
cell
fig
rel
b
cell
popul
variabl
group
signific
differ
shown
fig
mperspecif
antibodi
detect
mice
receiv
slayer
proteinspecif
antibodi
detect
anim
receiv
lactobacilli
b
cell
produc
mperspecif
iga
larg
intestin
femal
detect
mper
epitop
slayer
slpa
protein
use
mab
total
cell
protein
purifi
slayer
protein
separ
sdspage
gel
stain
cbb
blot
onto
pvdf
membran
follow
western
blot
analysi
use
antimp
monoclon
human
igg
c
expos
mper
epitop
detect
flow
cytometri
l
acidophilu
strain
label
alexa
fluor
antihuman
igg
analyz
rel
fluoresc
intens
strain
shown
histogram
plot
reproduct
tract
quantifi
elispot
assay
shown
fig
mperspecif
igaposit
cell
detect
almost
exclus
group
result
suggest
adjuv
effect
requir
enhanc
immunogen
mper
contain
slpa
cytokin
produc
spleen
cell
respons
restimul
mper
peptid
slayer
protein
also
analyz
fig
cytokin
rare
detect
mperstimul
nonstimul
splenocyt
cultur
meanwhil
moder
amount
multipl
cytokin
especi
releas
spleen
cell
stimul
slayer
protein
mice
receiv
l
acidophilu
strain
sinc
titer
antigenspecif
ab
appear
reach
plateau
termin
point
fig
second
studi
perform
mice
receiv
total
immun
week
mice
immun
develop
mperspecif
igg
sera
respons
plateau
fig
shown
fig
endpoint
titer
mperspecif
serum
igg
much
higher
first
studi
mucos
iga
specif
mper
also
detect
immun
mice
individu
mperspecif
igg
also
present
vagin
lavag
fluid
result
indic
addit
boost
evok
readili
detect
level
system
mucos
mperspecif
ab
respons
addit
boost
also
show
capabl
induc
mperspecif
ab
product
respons
shown
fig
isotyp
analysi
mperspecif
serum
antibodi
induc
reveal
domin
albeit
small
part
antimp
could
detect
due
low
sensit
assay
fig
slayer
protein
domin
cellsurfac
compon
bacteria
serv
scaffold
function
peptid
abund
slayer
protein
may
effici
mean
display
specif
vaccin
epitop
compar
surfac
display
approach
lpxtganchor
protein
flagella
present
studi
show
mutant
l
acidophilu
display
mper
success
establish
modif
slpa
gene
high
frequenc
epitop
bacteri
surfac
demonstr
flow
cytometri
immunoblot
assay
importantli
mab
recogn
mper
peptid
expos
slayer
protein
suggest
heterolog
peptid
reproduc
correspond
structur
present
insert
peptid
longer
amino
acid
slpa
protein
without
destruct
effect
slayer
structur
difficult
unpublish
data
work
ongo
success
engin
insert
longer
andor
multipl
peptid
previou
studi
slayer
protein
differ
l
acidophilu
strain
lactobacillu
brevi
strain
engin
includ
cmyc
epitop
although
immunolog
properti
determin
scheppler
et
al
report
immun
mice
recombin
lactobacillu
johnsonii
strain
express
prtb
cell
wall
anchor
proteinas
lactobacillu
delbrueckii
subsp
bulgaricu
insert
mimotop
tetanu
toxin
induc
antibodi
specif
bacteri
cell
prtb
mimotop
emphas
display
epitop
bacteri
surfac
guarante
immunogen
henc
investig
whether
mper
slpa
could
elicit
specif
immun
respons
vivo
preliminari
experi
l
acidophilu
weakli
immunogen
antibodi
respons
mper
improv
mucos
immunogen
matur
murin
employ
sinc
famili
protein
known
act
mucos
adjuv
previous
show
biolog
activ
produc
secret
anoth
recombin
lactobacillu
strain
first
round
g
immun
recombin
strain
refer
strain
mperspecif
ab
specif
igaproduc
cell
detect
exclus
group
receiv
strain
hand
slpaspecif
respons
reli
cytokin
result
impli
induct
mperspecif
slpaspecif
ab
adjuvantdepend
howev
second
trial
mice
receiv
four
addit
boost
l
acidophilu
strain
eventu
elicit
mperspecif
ab
respons
regardless
coexpress
suggest
essenti
possibl
expedit
specif
immun
respons
addit
studi
need
confirm
adjuv
effect
better
defin
mechan
action
although
mani
studi
employ
recombin
lactic
acid
bacteria
vaccin
deliveri
littl
inform
antivector
respons
report
current
studi
show
repeat
high
dose
immun
l
acidophilu
evok
slayer
proteinspecif
antibodi
cytokin
respons
splenocyt
isol
mice
immun
l
acidophilu
strain
restimul
purifi
slayer
protein
product
sever
cytokin
markedli
upregul
notabl
suggest
system
immun
respons
specif
slayer
protein
domin
sinc
pattern
cytokin
product
group
treat
l
acidophilu
strain
similar
regardless
slpamut
coexpress
respons
like
attribut
natur
slayer
protein
per
se
slpa
l
acidophilu
previous
shown
induc
cytokin
product
dendrit
cell
via
dcsign
vitro
current
studi
reveal
role
slayer
protein
adapt
immun
respons
vivo
contrast
slayer
protein
vitro
restimul
splenocyt
mper
peptid
induc
littl
cytokin
product
suggest
mper
peptid
embed
slayer
protein
stimul
cell
respons
mperspecif
antibodi
respons
cell
independ
isotyp
analysi
reveal
major
subclass
mperspecif
antibodi
known
evok
cell
independ
manner
involv
switch
previous
report
mention
slayer
protein
stimul
respons
known
requir
taken
togeth
produc
respons
slayer
protein
l
acidophilu
may
drive
facilit
cell
independ
antibodi
respons
mper
could
import
featur
l
acidophilu
vaccin
platform
given
grow
gener
concern
vectorinduc
cell
respons
may
enhanc
infect
prevent
transmiss
may
achiev
local
mucosa
natur
bottleneck
greatest
current
studi
demonstr
genet
engin
l
acidophilu
induc
mucos
system
antigenspecif
antibodi
repeat
mucos
immun
howev
function
characterist
induc
antibodi
remain
determin
classic
viru
neutral
may
essenti
mechan
reduc
likelihood
infecti
virion
contact
target
cell
sever
function
attribut
mucos
antibodi
describ
pathogen
neutral
includ
immun
exclus
intracellular
neutral
reversetranscytosi
immun
target
via
highaffin
iga
receptor
express
dendrit
cell
neutrophil
furthermor
local
elimin
earli
viru
target
via
antibodydepend
cellular
cytotox
could
creat
onetwo
punch
provid
signific
level
protect
without
need
rapid
immun
activ
clearli
remain
confirm
appropri
anim
model
whether
recombin
l
acidophilu
induc
protect
mucos
system
antibodi
respons
without
activ
mucos
cell
target
support
inform
fig
schemat
map
wildmodifi
slpa
gene
posit
primer
insert
site
mper
peptid
slpa
chosen
accord
studi
smit
et
al
polypeptid
mper
neqelleldkwaslwn
employ
previous
jain
et
al
select
insert
mper
peptideencod
sequenc
includ
primer
modifi
slpa
gene
bottom
includ
mperencod
nucleotid
sequenc
gener
wild
type
slpa
gene
top
use
overlap
pcr
arrow
number
repres
primer
p
promot
slpa
gene
termin
slpa
gene
mperencod
nucleotid
